A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy
- 1 January 1994
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 170 (1) , 90-95
- https://doi.org/10.1016/s0002-9378(94)70390-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Maternal thyroid disease and risk of birth defects in offspring: a population‐based case‐control studyPaediatric and Perinatal Epidemiology, 1989
- Reevaluation of the Effects of Methylmercaptoimidazole and Propylthiouracil in Patients with Graves' HyperthyroidismJournal of Clinical Endocrinology & Metabolism, 1987
- Antithyroid Drug Therapy for Graves' Disease during PregnancyNew England Journal of Medicine, 1986
- Which anti-thyroid drug?The American Journal of Medicine, 1986
- Pharmacology of Propylthiouracil (PTU) in Pregnant Hyperthyroid Women: Correlation of Maternal PTU Concentrations with Cord Serum Thyroid Function Tests*Journal of Clinical Endocrinology & Metabolism, 1986
- Scalp defects in infants of mothers treated for hyperthyroidism with methimazole or carbimazole during pregnancyTeratology, 1985
- The Management of Thyrotoxicosis in PregnancyNew England Journal of Medicine, 1985
- Treatment of maternal hyperthyroidism with antithyroid agents and changes in thyrotrophin and thyroxine in the newbornActa Endocrinologica, 1981
- The Placental Transfer of Propylthiouracil, Methimazole and CarbimazoleJournal of Clinical Endocrinology & Metabolism, 1977
- Re-evaluation of Thyroxine Binding and Free Thyroxine in Human Serum by Paper Electrophoresis and Equilibrium Dialysis, and a New Free Thyroxine Index1Journal of Clinical Endocrinology & Metabolism, 1970